The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells
Crossref DOI link: https://doi.org/10.1186/s12885-015-1967-5
Published Online: 2015-12-16
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Greve, Gabriele
Schiffmann, Insa
Pfeifer, Dietmar
Pantic, Milena
Schüler, Julia
Lübbert, Michael
License valid from 2015-12-01